Glucosamine Pharma Nord 400 mg Capsules

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Glucosamine

Available from:

Pharma Nord ApS

ATC code:

M01AX; M01AX05

INN (International Name):

Glucosamine

Dosage:

400 Milligrams per capsule

Pharmaceutical form:

Capsule, hard

Prescription type:

Product subject to prescription which may be renewed (B)

Therapeutic area:

Other antiinflammatory and antirheumatic agents, non-steroids; glucosamine

Authorization status:

Marketed

Authorization date:

2005-10-28

Patient Information leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER
GLUCOSAMINE PHARMA NORD 400 MG HARD CAPSULES
Glucosamine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
Ask your pharmacist if you need more information or advice.
•
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4.
•
You must talk to a doctor if you do not feel better or if you feel
worse after 30 days.
WHAT IS IN THIS LEAFLET
1.
What Glucosamine Pharma Nord is and what it is used for
2.
What you need to know before you take Glucosamine Pharma Nord
3.
How to take Glucosamine Pharma Nord
4.
Possible side effects
5.
How to store Glucosamine Pharma Nord
6.
Contents of the pack and other information
1.
WHAT GLUCOSAMINE PHARMA NORD IS AND WHAT IT IS USED FOR
Glucosamine Pharma Nord belongs to the group of medicines called
non-steroid anti-inflammatory
and anti rheumatic drugs.
Glucosamine Pharma Nord capsules are used for the relief of symptoms
in mild to moderate
osteoarthritis of the knee.
Your doctor may have given you Glucosamine Pharma Nord for other use.
Always follow your
doctor’s instructions.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE GLUCOSAMINE PHARMA
NORD
_ _
DO NOT TAKE GLUCOSAMINE PHARMA NORD
•
if you are allergic (hypersensitive) to glucosamine or to any of the
other ingredients.
•
if you are allergic (hypersensitive) to shellfish, as the active
substance is extracted from
shellfish.
TAKE SPECIAL CARE WITH GLUCOSAMINE PHARMA NORD
Before you start treatment with Glucosamine Pharma Nord you should
visit your doctor to exclude the
presence of joint diseases which needs other treatment.
Glucosamine Pharma Nord contains 2.2 mmol (87 mg) potassium per
capsule. To be taken into
consideration by patients with reduced kidney function or patients on
a controlled potassium diet.
Tell also your doctor:
•
if you have a known incr

Summary of Product characteristics

Health Products Regulatory Authority
10 November 2023
CRN00DSVY
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Glucosamine Pharma Nord 400 mg Capsules
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
400 mg glucosamine, corresponding to 509 mg glucosamine hemisulphate,
corresponding to 676 mg glucosamine
hemisulphate-potassium chloride complex (1:1).
Each capsule contains 2.2 mmol (87 mg) potassium.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Capsule, hard
Yellow-coloured, hard capsule (size 0).
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Relief of symptoms of mild to moderate osteoarthritis of the knee.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
400 mg glucosamine (1 capsule) three times daily. Alternatively, the
daily dose can be taken on one occasion.
The capsule(s) should be taken with a full glass of water. The
capsules can be taken with or without food.
Glucosamine Pharma Nord is not indicated for acute relief of
osteoarthritis pain. Relief of symptoms (especially pain relief) may
not be experienced until after several weeks of treatment and in some
cases even longer. If no relief of symptoms is
experienced after 2-3 months, continued treatment with glucosamine
should be re-evaluated.
Elderly: No adjustment of dose is required with the treatment of
elderly patients.
Children: Glucosamine Pharma Nord is not receommended for use in
children or adolescents under the age of 18 years due to
insufficient experience.
Reduced kidney and/or liver function: As patients with reduced kidney
and/or liver function have not been specifically studied,
no recommendations regarding dose can be given. The potassium content
of Glucosamine Pharma Nord should be taken into
consideration by patients with reduced kidney function (see section
4.4).
4.3 CONTRAINDICATIONS
Persons allergic to shellfish should not use Glucosamine Pharma Nord
as the active substance is extracted from shellfish.
Hypersensitivity to glucosamine or to any of the excipients.
Health Products Regulator